Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China flag China · Delayed Price · Currency is CNY
39.98
+0.89 (2.28%)
At close: May 12, 2026

SHA:688163 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
48.651.7944.2938.7764.276.48
Depreciation & Amortization
19.2919.2919.9717.1614.915.04
Other Amortization
0.240.240.370.240.240.24
Loss (Gain) From Sale of Assets
-0.08-0.08-1.44--0.25
Asset Writedown & Restructuring Costs
0.720.721.030.02-0.951.02
Loss (Gain) From Sale of Investments
-9.18-9.181.01-10.33-16.040.79
Provision & Write-off of Bad Debts
--0.740.79-0.530.6
Other Operating Activities
12.890.543.214.390.190.83
Change in Accounts Receivable
-8.49-8.49-10.42-22.993.2-4.48
Change in Inventory
-1.83-1.83-1.566.13-4.33-0.48
Change in Accounts Payable
6.046.04-4.32-0.57.871
Change in Other Net Operating Assets
-----0.79
Operating Cash Flow
69.760.5350.2532.8267.9192.29
Operating Cash Flow Growth
36.35%20.46%53.12%-51.67%-26.41%-6.17%
Capital Expenditures
-78.52-59.61-59.37-28.67-26.46-27.61
Sale of Property, Plant & Equipment
0.130.130.010.02-0.33
Investment in Securities
-264.69-124.9970.83-305-349.85-65
Other Investing Activities
10.510.385.2717.7115.891.76
Investing Cash Flow
-332.59-174.0916.73-315.94-360.42-90.52
Long-Term Debt Repaid
---1.15-0.69-1.34-1.31
Net Debt Issued (Repaid)
---1.15-0.69-1.34-1.31
Issuance of Common Stock
----790.61-
Common Dividends Paid
-34.63-34.63-34.63-81.16-97.39-
Dividends Paid
-34.63-34.63-34.63-81.16-97.39-
Other Financing Activities
-0.81-0.69----2.7
Financing Cash Flow
-35.44-35.32-35.77-81.84691.87-4.01
Foreign Exchange Rate Adjustments
0.040.05-0.030.160.49-0.12
Net Cash Flow
-298.29-148.8331.19-364.81399.85-2.36
Free Cash Flow
-8.830.93-9.124.1541.4664.68
Free Cash Flow Growth
----90.00%-35.91%-19.58%
Free Cash Flow Margin
-4.46%0.47%-4.68%2.18%23.79%30.99%
Free Cash Flow Per Share
-0.100.01-0.080.040.410.80
Cash Income Tax Paid
18.318.6313.3325.0212.8616.85
Levered Free Cash Flow
-19.47-19.16-23.72-3.932.1634.48
Unlevered Free Cash Flow
-19.47-19.16-23.45-3.532.5834.93
Change in Working Capital
-2.79-2.79-18.93-18.225.9-2.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.